70
Views
0
CrossRef citations to date
0
Altmetric
Review

Relationship between obstructive sleep apnea and pulmonary hypertension: past, present and future

, , &
Received 08 Nov 2023, Accepted 17 Apr 2024, Published online: 24 Apr 2024

References

  • Bonsignore MR, Baiamonte P, Mazzuca E, et al. Obstructive sleep apnea and comorbidities: a dangerous liaison. Multidiscip Respir Med. 2019;14. doi: 10.4081/mrm.2019.10
  • McNicholas WT. Obstructive sleep apnoea and comorbidity–an overview of the association and impact of continuous positive airway pressure therapy. Expert Rev Respir Med. 2019;13:251–261. doi: 10.1080/17476348.2019.1575204
  • Gleeson M, McNicholas WT. Bidirectional relationships of comorbidity with obstructive sleep apnoea. Eur Respir Rev. 2022;31(164):210256. doi: 10.1183/16000617.0256-2021
  • The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, version 3. Available from: www.aasmnet.org.
  • Sateia MJ. International classification of sleep disorders-third edition. Chest. 2014;146(5):1387–1394. doi: 10.1378/chest.14-0970
  • Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913. doi: 10.1183/13993003.01913-2018
  • Humbert M, Kovacs G, Hoeper MM, et al. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2022;61(1):2200879. doi: 10.1183/13993003.00879-2022. 2023.
  • Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687–698. doi: 10.1016/S2213-2600(19)30198-5
  • Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5(2):136–143. doi: 10.1513/pats.200709-155MG
  • Lee W, Nagubadi S, Kryger MH, et al. Epidemiology of obstructive sleep apnea: a population-based perspective. Expert Rev Respir Med. 2008;2(3):349–364. doi: 10.1586/17476348.2.3.349
  • Kholdani C, Fares WH, Mohsenin V. Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology. Pulm Circ. 2015;5(2):220–227. doi: 10.1086/679995
  • Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015 Apr 1;3(4):310–318. doi: 10.1016/S2213-2600(15)00043-0
  • Kapur V, Strohl KP, Redline S, et al. Underdiagnosis of sleep apnea syndrome in U.S. communities. Sleep Breathing. 2002;6(2):049–054. doi: 10.1055/s-2002-32318
  • Young T, Evans L, Finn L, et al. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep. 1997;20(9):705–706. doi: 10.1093/sleep/20.9.705
  • Thornton JD, Dudley KA, Saeed GJ, et al. Differences in symptoms and severity of obstructive sleep apnea between black and white patients. Ann Am Thorac Soc. 2022;19(2):272–278. doi: 10.1513/AnnalsATS.202012-1483OC
  • Stanchina ML. Health inequities and racial disparity in obstructive sleep apnea diagnosis: a call for action. Ann ATS. 2022;19(2):169–170. doi: 10.1513/AnnalsATS.202108-984ED
  • Hoeper MM, Humbert M, Souza R, et al. A global view of pulmonary hypertension. Lancet Respir Med. 2016;4(4):306–322. doi: 10.1016/S2213-2600(15)00543-3
  • Thiwanka Wijeratne D, Lajkosz K, Brogly SB, et al. Increasing incidence and prevalence of world health organization groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada. Circ Cardiovasc Qual Outcomes. 2018 Feb 1;11(2). doi: 10.1161/CIRCOUTCOMES.117.003973
  • Pugh ME, Sivarajan L, Wang L, et al. Causes of pulmonary hypertension in the elderly. Chest Am Col Chest Phys. 2014;146(1):159–166. doi: 10.1378/chest.13-1900
  • Anderson JJ, Lau EM. Pulmonary hypertension definition, classification, and epidemiology in Asia. Vol. 2. Asia: JACC; 2022.
  • Hidden health crisis costing America billions underdiagnosing and undertreating obstructive sleep apnea draining healthcare system. 2016.
  • Javaheri S, Caref EB, Chen E, et al. Sleep apnea testing and outcomes in a large cohort of medicare beneficiaries with newly diagnosed heart failure. Am J Respir Crit Care Med. 2011;183(4). doi: 10.1164/rccm.201003-0406OC
  • Wickwire EM. Value-based sleep and breathing: health economic aspects of obstructive sleep apnea. Fac Rev. 2021 Apr 19;10. doi: 10.12703/r/10-40
  • Heresi GA, Joish VN, Platt D, et al. Incremental burden of group 3 pulmonary hypertension patients to U.S. payer. Value Health. 2015;18(3):A253. doi: 10.1016/j.jval.2015.03.1474
  • Heresi GA, Platt DM, Wang W, et al. Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia. BMC Pulm Med. 2017;17(1). doi: 10.1186/s12890-017-0399-1
  • Chaouat A, Weitzenblum E, Krieger J, et al. Pulmonary hemodynamics in the obstructive sleep apnea syndrome results in 220 consecutive patients. Chest. 1996;109(2):380–386. doi: 10.1378/chest.109.2.380
  • Krieger J, Sforza E, Apprill M, et al. Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients. Chest. 1989;96(4):729–737. doi: 10.1378/chest.96.4.729
  • Sajkov D, Wang T, Saunders NA, et al. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med. 1999;159(5):1518–1526. doi: 10.1164/ajrccm.159.5.9805086
  • Bady E, Achkar A, Pascal S, et al. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax. 2000;55(11):934–939. doi: 10.1136/thorax.55.11.934
  • Minai OA, Ricaurte B, Kaw R, et al. Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am J Cardiol. 2009;104(9):1300–1306. doi: 10.1016/j.amjcard.2009.06.048
  • OSA PH parameters CHEST. 2023.
  • ROBIN ED, WHALEY RD, CRUMP CH, et al. Alveolar gas tensions, pulmonary ventilation and blood pH during physiologic sleep in normal subjects. J Clin Invest. 1958;37(7):981–989. doi: 10.1172/JCI103694
  • Kimura H, Ota H, Kimura Y, et al. Effects of intermittent hypoxia on pulmonary vascular and systemic diseases. Int J Environ Res Public Health. 2019;16(17):3101. doi: 10.3390/ijerph16173101
  • Sowho M, Amatoury J, Kirkness JP, et al. Sleep and respiratory physiology in adults. Clin Chest Med. 2014;35(3):469–481. doi: 10.1016/j.ccm.2014.06.002
  • Marrone O, Bellia V, Ferrara G, et al. Transmural pressure measurements. Importance in the assessment of pulmonary hypertension in obstructive sleep apneas. Chest. 1989;95(2):338–343. doi: 10.1378/chest.95.2.338
  • Budhiraja R, Parthasarathy S, Quan SF. Endothelial dysfunction in obstructive sleep apnea. J Clin Sleep Med. 2007;3(4):409–415. doi: 10.5664/jcsm.26864
  • Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99(7):675–691. doi: 10.1161/01.RES.0000243584.45145.3f
  • Ip MSM, Tse HF, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004;169(3):348–353. doi: 10.1164/rccm.200306-767OC
  • Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000;102(21):2607–2610. doi: 10.1161/01.CIR.102.21.2607
  • Harki O, Boete Q, Pépin JL, et al. Intermittent hypoxia-related alterations in vascular structure and function: a systematic review and meta-analysis of rodent data. Eur Respir J. 2022;59(3):2100866. doi: 10.1183/13993003.00866-2021
  • Lavie L. Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea. Front Biosci - Elite. 2012;4 E(1):1391. doi: 10.2741/469
  • Phillips BG, Narkiewicz K, Pesek CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17(1):61–66. doi: 10.1097/00004872-199917010-00010
  • Schulz R, Hummel C, Heinemann S, et al. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med. 2002;165(1):67–70. doi: 10.1164/ajrccm.165.1.2101062
  • Chaszczewska-Markowska M, Górna K, Bogunia-Kubik K, et al. The influence of comorbidities on chemokine and cytokine profile in obstructive sleep apnea patients: preliminary results. J Clin Med. 2023;12(3):801. doi: 10.3390/jcm12030801
  • Lüscher TF. Inflammation: the new cardiovascular risk factor. Eur Heart J. 2018;39(38):3483–3487. doi: 10.1093/eurheartj/ehy607
  • Marrone O, Bonsignore MR, Romano S, et al. Slow and fast changes in transmural pulmonary artery pressure in obstructive sleep apnoea. Eur Respir J. 1994;7(12):2192–2198. doi: 10.1183/09031936.94.07122192
  • Noda A, Nakata S, Koike Y, et al. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res. 2007;30(8):669–676. doi: 10.1291/hypres.30.669
  • Sajkov D, McEvoy RD. Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis. 2009 Mar;51(5):363–370. doi: 10.1016/j.pcad.2008.06.001
  • Tadic M, Cuspidi C. Obstructive sleep apnea and right ventricular remodeling: do we have all the answers? J Clin Med. 2023;12(6):2421. doi: 10.3390/jcm12062421
  • Arias MA, García-Río F, Alonso-Fernández A, et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation. 2005;112(3):375–383. doi: 10.1161/CIRCULATIONAHA.104.501841
  • Alchanatis M, Paradellis G, Pini H, et al. Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration. 2000;67(4):367–371. doi: 10.1159/000029532
  • Naeije R. Pulmonary hypertension in hypoventilation syndromes. Eur Respir J. 2014;43(1):12–15. doi: 10.1183/09031936.00185213
  • Corral J, Mogollon MV, Sánchez-Quiroga MÁ, et al. Echocardiographic changes with non-invasive ventilation and CPAP in obesity hypoventilation syndrome. Thorax. 2018;73(4):361–368. doi: 10.1136/thoraxjnl-2017-210642
  • Held M, Walthelm J, Baron S, et al. Functional impact of pulmonary hypertension due to hypoventilation and changes under noninvasive ventilation. Eur Respir J. 2014;43(1):156–165. doi: 10.1183/09031936.00147712
  • Nathan SD, Barbera JA, Gaine SP, et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2020;53(1):1801914. doi: 10.1183/13993003.01914-2018
  • Huang Z, Duan A, Hu M, et al. Implication of prolonged nocturnal hypoxemia and obstructive sleep apnea for pulmonary hemodynamics in patients being evaluated for pulmonary hypertension: a retrospective study. J Clin Sleep Med. 2023;19(2):213–223. doi: 10.5664/jcsm.10286
  • Samhouri B, Venkatasaburamini M, Mar HPY, et al. Pulmonary artery hemodynamics are associated with duration of nocturnal desaturation but not apnea-hypopnea index. J Clin Sleep Med. 2020;16(8):1231–1239. doi: 10.5664/jcsm.8468
  • Prisco DL, Sica AL, Talwar A, et al. Correlation of pulmonary hypertension severity with metrics of comorbid sleep-disordered breathing. Sleep Breathing. 2011;15(4):633–639. doi: 10.1007/s11325-010-0411-y
  • Varghese L, Rebekah G, Priya N, et al. Oxygen desaturation index as alternative parameter in screening patients with severe obstructive sleep apnea. Sleep Sci. 2022;15(S 01):224–228. doi: 10.5935/1984-0063.20200119
  • Liu X, Lam DCL, Mak HKF, et al. Associations of sleep apnea risk and oxygen desaturation indices with cerebral small vessel disease burden in patients with stroke. Front Neurol. 2022;13. doi: 10.3389/fneur.2022.956208
  • Liu Y, Abdul Ghafoor A, Hajipour M, et al. Role of precision medicine in obstructive sleep apnoea. BMJ Med. 2023;2(1):e000218. doi: 10.1136/bmjmed-2022-000218
  • Labarca G, Vena D, Hu WH, et al. Sleep apnea physiological burdens and cardiovascular morbidity and mortality. Am J Respir Crit Care Med. 2023;208(7):802–813. doi: 10.1164/rccm.202209-1808OC
  • Trzepizur W, Blanchard M, Ganem T, et al. Sleep apnea–specific hypoxic burden, symptom subtypes, and risk of cardiovascular events and all-cause mortality. Am J Respir Crit Care Med. 2022;205(1):108–117. doi: 10.1164/rccm.202105-1274OC
  • Parekh A, Kam K, Wickramaratne S, et al. Ventilatory burden as a measure of obstructive sleep apnea severity is predictive of cardiovascular and all-cause mortality. Am J Respir Crit Care Med. 2023;208(11):1216–1226. doi: 10.1164/rccm.202301-0109OC
  • Wickramaratne S, Kam K, Tolbert TM, et al. Combination of ventilatory, hypoxic, and arousal burden predicts short- and long-term consequences of OSA better than the apnea-hypopnea index. 2023.
  • Martinez-Garcia MA, Campos-Rodriguez F, Barbé F, et al. Precision medicine in obstructive sleep apnoea. Lancet Respir Med. 2019;7(5):456–464. doi: 10.1016/S2213-2600(19)30044-X
  • Light M, Owens RL, Schmickl CN, et al. Precision medicine for obstructive sleep apnea. Sleep Med Clin. 2019;14(3):391–398. doi: 10.1016/j.jsmc.2019.05.005
  • Malhotra A, Mesarwi O, Pepin JL, et al. Endotypes and phenotypes in obstructive sleep apnea. Curr Opin Pulm Med. 2020;26(6):609–614. doi: 10.1097/MCP.0000000000000724
  • Turnbull CD, Stradling JR. Endotyping, phenotyping and personalised therapy in obstructive sleep apnoea: are we there yet? Thorax. 2023;78(7):726–732. doi: 10.1136/thorax-2023-220037
  • Zinchuk A, Yaggi HK. Phenotypic subtypes of OSA: a challenge and opportunity for precision medicine. Chest. 2020;157(2):403–420. doi: 10.1016/j.chest.2019.09.002
  • Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest. 2010;137(2):376–387. doi: 10.1378/chest.09-1140
  • Minic M, Granton JT, Ryan CM. Sleep disordered breathing in group 1 pulmonary arterial hypertension. J Clin Sleep Med. 2014;10(3):277–283. doi: 10.5664/jcsm.3528
  • Murta MS, Duarte RLM, Waetge D, et al. Sleep-disordered breathing in adults with precapillary pulmonary hypertension: prevalence and predictors of nocturnal hypoxemia. Lung. 2022;200(4):523–530. doi: 10.1007/s00408-022-00547-w
  • Jilwan FN, Escourrou P, Garcia G, et al. High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms. Chest. 2013;143(1):47–55. doi: 10.1378/chest.11-3124
  • White LH, Bradley TD. Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea. J Phy. 2013;591(5):1179–1193. doi: 10.1113/jphysiol.2012.245159
  • Jutant EM, Montani D, Sattler C, et al. Hypoxemia during sleep and overnight rostral fluid shift in pulmonary arterial hypertension: a pilot study. Pulm Circ. 2021;11(2):1–9. doi: 10.1177/2045894021996930
  • Riou M, Pizzimenti M, Enache I, et al. Skeletal and respiratory muscle dysfunctions in pulmonary arterial hypertension. J Clin Med. 2020;9(2):410. doi: 10.3390/jcm9020410
  • Yan L, Zhao Z, Zhao Q, et al. The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea. BMC Pulm Med. 2021;21(1). doi: 10.1186/s12890-021-01755-5
  • Ismail K, Roberts K, Manning P, et al. OSA and pulmonary hypertension: time for a new look. Chest. 2015 Mar 1;147(3):847–861. doi: 10.1378/chest.14-0614
  • Patil SP, Ayappa IA, Caples SM, et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2019;15(2):335–343. doi: 10.5664/jcsm.7640
  • Sajkov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165(2):152–158. doi: 10.1164/ajrccm.165.2.2010092
  • Schwarz EI, Puhan MA, Schlatzer C, et al. Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: a systematic review and meta-analysis. Respirology. 2015;20(6):889–895. doi: 10.1111/resp.12573
  • Jain S, Yingchoncharoen P, Nugent K. Effect of continuous positive airway pressure therapy in patient with obstructive sleep apnea and pulmonary hypertension a literature review inclusion and exclusion criteria. Card Rev [Internet]. 2023; Publish Ahead of Print. Available from: www.cardiologyinreview.com|
  • Atwood CW, McCrory D, Garcia JGN, et al. Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. Chest. 2004;126(1):72S–77S. doi: 10.1378/chest.126.1_suppl.72S
  • Samaranayake CB, Turnbull C, Neubauer S, et al. Right ventricular responses to CPAP therapy in obstructive sleep apnea: CMR analysis of the MOSAIC randomized trial. Pulm Circ. 2023;13(1). doi: 10.1002/pul2.12201
  • Tadic M, Gherbesi E, Faggiano A, et al. The impact of continuous positive airway pressure on cardiac mechanics: findings from a meta-analysis of echocardiographic studies. J Clin Hypertens (Greenwich, CT). 2022;24(7):795–803. doi: 10.1111/jch.14488
  • Arias MA, García-Río F, Alonso-Fernández A, et al. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J. 2006;27(9):1106–1113. doi: 10.1093/eurheartj/ehi807
  • Atkeson A, Yeh SY, Malhotra A, et al. Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis. 2009;51(5):351–362. doi: 10.1016/j.pcad.2008.08.002
  • Duncan AW, Oh TE, Hillman DR. PEEP and CPAP. Anaesth Intensive Care. 1986;14(3):236–250. doi: 10.1177/0310057X8601400304
  • Squier SB, Patil SP, Schneider H, et al. Effect of end-expiratory lung volume on upper airway collapsibility in sleeping men and women. J Appl Physiol. 2010;109(4):977–985. doi: 10.1152/japplphysiol.00080.2010
  • Behazin N, Jones SB, Cohen RI, et al. Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity. J Appl Physiol. 2010;108(1):212–218. doi: 10.1152/japplphysiol.91356.2008
  • Masa JF, Benítez ID, Javaheri S, et al. Risk factors associated with pulmonary hypertension in obesity hypoventilation syndrome. J Clin Sleep Med. 2022;18(4):983–992. doi: 10.5664/jcsm.9760

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.